Ali Bahrami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ali Bahrami has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Fatemeh Nouri
Department of Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
3 shared publications - Mohammad Taheri
Department of Medical Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3 shared publications - Mojdeh Mohammadi
Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
2 shared publications Fatemeh Golabchi
Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
1 shared publication- Kiana Kimiaei Asadi
Hamadan University of Medical Sciences, Hamadan, Iran, Hamadan, Iran
1 shared publication Maryam Banitorfi
Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
1 shared publication
Latest Publications
- 1 December 2023
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 13 (6) , 351-369
A Review on Nonviral, Nonbacterial Infectious Agents Toxicity Involved in Neurodegenerative Diseases
Neuronal death, decreased activity or dysfunction of neurotransmitters are some of the pathophysiological reasons for neurodegenerative diseases like Alzheimer's, Parkinson's and multiple sclerosis...
- 1 December 2023
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 13 (6) , 351-369
A Review on Nonviral, Nonbacterial Infectious Agents Toxicity Involved in Neurodegenerative Diseases
Neuronal death, decreased activity or dysfunction of neurotransmitters are some of the pathophysiological reasons for neurodegenerative diseases like Alzheimer's, Parkinson's and multiple sclerosis...
- Open Access
- 7 March 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-7
Harnessing the Natural Toxic Metabolites in COVID-19
SARS-CoV-2 is a novel coronavirus and the cause of the recent pandemic; it is an enveloped β-coronavirus. SARS-CoV-2 appear in the Wuhan City of China for the first time and outspread worldwide quickly. Due to its person-to-person fast transmission, COVID-19 is becoming a global problem. SARS-CoV-2 enter into cells by using ACE2 receptors that are numerous in the lungs and finally can cause acute respiratory distress syndrome (ARDS). Dry cough, sore throat, fever, body pain, headache, GIT discomfort, diarrhoea, and fatigue are some of the COVID-19 symptoms. There is no definite and certain treatment for disease caused by SARS-CoV-2 till now. Some pharmacological effects of toxins, toxoids, and venoms have been proven, and their effects on some diseases have been evaluated. This study aimed to investigate the role of toxins, toxoids, and venom in the pathophysiology of COVID-19 disease.
- 7 March 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-7
Open AccessHarnessing the Natural Toxic Metabolites in COVID-19
SARS-CoV-2 is a novel coronavirus and the cause of the recent pandemic; it is an enveloped β-coronavirus. SARS-CoV-2 appear in the Wuhan City of China for the first time and outspread worldwide quickly. Due to its person-to-person fast transmission, COVID-19 is becoming a global problem. SARS-CoV-2 enter into cells by using ACE2 receptors that are numerous in the lungs and finally can cause acute respiratory distress syndrome (ARDS). Dry cough, sore throat, fever, body pain, headache, GIT discomfort, diarrhoea, and fatigue are some of the COVID-19 symptoms. There is no definite and certain treatment for disease caused by SARS-CoV-2 till now. Some pharmacological effects of toxins, toxoids, and venoms have been proven, and their effects on some diseases have been evaluated. This study aimed to investigate the role of toxins, toxoids, and venom in the pathophysiology of COVID-19 disease.
- 8 September 2020
- Published by Springer Nature in Biological Trace Element Research
- Vol. 199 (7) , 2475-2481
A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19
All the world is involved in the COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus is a positive-sense RNA and has an envelope. There is no specific drug for this disease and treatment methods are limited. Malnutrition and electrolyte imbalance can make dysfunction in the immune system and impairment of the immune system causes increasing the risk of infection. Understanding the aspects of biological features of the virus will help the development of diagnostic tests, pharmacological therapies, and vaccines. Here, we review and discuss increasing and decreasing some trace elements and imbalance of serum and plasma electrolytes involving in COVID-19.
- 8 September 2020
- Published by Springer Nature in Biological Trace Element Research
- Vol. 199 (7) , 2475-2481
A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19
All the world is involved in the COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus is a positive-sense RNA and has an envelope. There is no specific drug for this disease and treatment methods are limited. Malnutrition and electrolyte imbalance can make dysfunction in the immune system and impairment of the immune system causes increasing the risk of infection. Understanding the aspects of biological features of the virus will help the development of diagnostic tests, pharmacological therapies, and vaccines. Here, we review and discuss increasing and decreasing some trace elements and imbalance of serum and plasma electrolytes involving in COVID-19.